Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Accumulated Expenses: 2022-2025

Historic Accumulated Expenses for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $21.6 million.

  • Praxis Precision Medicines' Accumulated Expenses rose 39.92% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year increase of 39.92%. This contributed to the annual value of $23.8 million for FY2024, which is 220.43% up from last year.
  • As of Q3 2025, Praxis Precision Medicines' Accumulated Expenses stood at $21.6 million, which was up 13.71% from $19.0 million recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' Accumulated Expenses registered a high of $30.9 million during Q1 2022, and its lowest value of $7.0 million during Q1 2024.
  • Moreover, its 3-year median value for Accumulated Expenses was $13.3 million (2023), whereas its average is $13.6 million.
  • Per our database at Business Quant, Praxis Precision Medicines' Accumulated Expenses crashed by 69.76% in 2023 and then skyrocketed by 220.43% in 2024.
  • Quarterly analysis of 4 years shows Praxis Precision Medicines' Accumulated Expenses stood at $15.8 million in 2022, then tumbled by 53.21% to $7.4 million in 2023, then skyrocketed by 220.43% to $23.8 million in 2024, then spiked by 39.92% to $21.6 million in 2025.
  • Its last three reported values are $21.6 million in Q3 2025, $19.0 million for Q2 2025, and $15.5 million during Q1 2025.